FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283462641> ?p ?o ?g. }

• W4283462641 endingPage "336" @default.
• W4283462641 startingPage "328" @default.
• W4283462641 abstract "This secondary analysis aimed to investigate the effects of a 12 months intensive exercise-based lifestyle intervention on systemic markers of oxidative stress in persons with type 2 diabetes. We hypothesized lifestyle intervention to be superior to standard care in decreasing levels of oxidative stress. The study was based on the single-centre, assessor-blinded, randomised, controlled U-turn trial (ClinicalTrial.gov NCT02417012). Persons with type 2 diabetes ˂ 10 years, ˂ 3 glucose lowering medications, no use of insulin, BMI 25–40 kg/m2 and no severe diabetic complications were included. Participants were randomised (2:1) to either intensive exercise-based lifestyle intervention and standard (n = 64) or standard care alone (n = 34). Standard care included individual education in diabetes management, advice on a healthy lifestyle and regulation of medication by a blinded endocrinologist. The lifestyle intervention included five to six aerobic exercise sessions per week, combined with resistance training two to three times per week and an adjunct dietary intervention aiming at reduction of ∼500 kcal/day (month 0–4). The diet was isocaloric from months 5–12. The primary outcome of this secondary analysis was change in oxidative stress measured by 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and secondarily in 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG), as markers of RNA and DNA oxidation, respectively, from baseline to 12-months follow-up. A total of 77 participants, 21 participants receiving standard care and 56 participants receiving the lifestyle intervention, were included in the analysis. Mean age at baseline was 54.1 years (SD 9.1), 41% were women and mean duration of type 2 diabetes was 5.0 years (SD 2.8). From baseline to follow-up the lifestyle group experienced a 7% decrease in 8-oxoGuo (−0.15 nmol/mmol creatinine [95% CI -0.27, −0.03]), whereas standard care conversely was associated with a 8.5% increase in 8-oxoGuo (0.19 nmol/mmol creatinine [95% CI 0.00, 0.40]). The between group difference in 8-oxoGuo was −0.35 nmol/mmol creatinine [95% CI -0.58, −0.12,], p = 0.003. No between group difference was observed in 8-oxodG. A 12 months intensive exercise-based lifestyle intervention was associated with a decrease in RNA, but not DNA, oxidation in persons with type 2 diabetes." @default.
• W4283462641 created "2022-06-26" @default.
• W4283462641 creator A5001134228 @default.
• W4283462641 creator A5033826448 @default.
• W4283462641 creator A5047661122 @default.
• W4283462641 creator A5051857476 @default.
• W4283462641 creator A5056776121 @default.
• W4283462641 creator A5064550700 @default.
• W4283462641 creator A5065526075 @default.
• W4283462641 creator A5066860354 @default.
• W4283462641 creator A5072411696 @default.
• W4283462641 creator A5074362044 @default.
• W4283462641 creator A5085841382 @default.
• W4283462641 date "2022-08-01" @default.
• W4283462641 modified "2023-10-14" @default.
• W4283462641 title "Effects of an exercise-based lifestyle intervention on systemic markers of oxidative stress and advanced glycation endproducts in persons with type 2 diabetes: Secondary analysis of a randomised clinical trial" @default.
• W4283462641 cites W172609984 @default.
• W4283462641 cites W1967265218 @default.
• W4283462641 cites W1978890783 @default.
• W4283462641 cites W1986014108 @default.
• W4283462641 cites W1991460472 @default.
• W4283462641 cites W2005715757 @default.
• W4283462641 cites W2029853631 @default.
• W4283462641 cites W2074509155 @default.
• W4283462641 cites W2074756738 @default.
• W4283462641 cites W2086434878 @default.
• W4283462641 cites W2108762011 @default.
• W4283462641 cites W2110418106 @default.
• W4283462641 cites W2117866456 @default.
• W4283462641 cites W2118261488 @default.
• W4283462641 cites W2119307913 @default.
• W4283462641 cites W2130310020 @default.
• W4283462641 cites W2138936938 @default.
• W4283462641 cites W2150367899 @default.
• W4283462641 cites W2167798032 @default.
• W4283462641 cites W2183649177 @default.
• W4283462641 cites W2190409916 @default.
• W4283462641 cites W2412299019 @default.
• W4283462641 cites W2471605942 @default.
• W4283462641 cites W2557219951 @default.
• W4283462641 cites W2560794920 @default.
• W4283462641 cites W2610851713 @default.
• W4283462641 cites W2626447691 @default.
• W4283462641 cites W2745682767 @default.
• W4283462641 cites W2748939874 @default.
• W4283462641 cites W2765283031 @default.
• W4283462641 cites W2784569646 @default.
• W4283462641 cites W2796371952 @default.
• W4283462641 cites W2801912370 @default.
• W4283462641 cites W2948309843 @default.
• W4283462641 cites W3003389578 @default.
• W4283462641 cites W3023235690 @default.
• W4283462641 cites W3035534275 @default.
• W4283462641 cites W3053977359 @default.
• W4283462641 cites W3112593059 @default.
• W4283462641 cites W3119870331 @default.
• W4283462641 cites W3163469396 @default.
• W4283462641 cites W3199391333 @default.
• W4283462641 cites W3213416726 @default.
• W4283462641 cites W3215823389 @default.
• W4283462641 cites W4205571543 @default.
• W4283462641 doi "https://doi.org/10.1016/j.freeradbiomed.2022.06.013" @default.
• W4283462641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35764194" @default.
• W4283462641 hasPublicationYear "2022" @default.
• W4283462641 type Work @default.
• W4283462641 citedByCount "10" @default.
• W4283462641 countsByYear W42834626412022 @default.
• W4283462641 countsByYear W42834626412023 @default.
• W4283462641 crossrefType "journal-article" @default.
• W4283462641 hasAuthorship W4283462641A5001134228 @default.
• W4283462641 hasAuthorship W4283462641A5033826448 @default.
• W4283462641 hasAuthorship W4283462641A5047661122 @default.
• W4283462641 hasAuthorship W4283462641A5051857476 @default.
• W4283462641 hasAuthorship W4283462641A5056776121 @default.
• W4283462641 hasAuthorship W4283462641A5064550700 @default.
• W4283462641 hasAuthorship W4283462641A5065526075 @default.
• W4283462641 hasAuthorship W4283462641A5066860354 @default.
• W4283462641 hasAuthorship W4283462641A5072411696 @default.
• W4283462641 hasAuthorship W4283462641A5074362044 @default.
• W4283462641 hasAuthorship W4283462641A5085841382 @default.
• W4283462641 hasBestOaLocation W42834626411 @default.
• W4283462641 hasConcept C103038586 @default.
• W4283462641 hasConcept C126322002 @default.
• W4283462641 hasConcept C134018914 @default.
• W4283462641 hasConcept C168563851 @default.
• W4283462641 hasConcept C1862650 @default.
• W4283462641 hasConcept C2776151105 @default.
• W4283462641 hasConcept C2777180221 @default.
• W4283462641 hasConcept C535046627 @default.
• W4283462641 hasConcept C555293320 @default.
• W4283462641 hasConcept C71924100 @default.
• W4283462641 hasConceptScore W4283462641C103038586 @default.
• W4283462641 hasConceptScore W4283462641C126322002 @default.
• W4283462641 hasConceptScore W4283462641C134018914 @default.
• W4283462641 hasConceptScore W4283462641C168563851 @default.
• W4283462641 hasConceptScore W4283462641C1862650 @default.
• W4283462641 hasConceptScore W4283462641C2776151105 @default.
• W4283462641 hasConceptScore W4283462641C2777180221 @default.

• next